TMO vs CAH
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs Cardinal Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | CAH |
|---|---|---|
| Price | $675.00 | $220.22 |
| Market cap | $249.58B | $50.99B |
| P/E ratio | 36.4 | 30.5 |
| ROE | 13.51% | — |
| Profit margin | 15.04% | 0.67% |
| Revenue growth | 10.50% | 5.80% |
| Dividend yield | 0.28% | 0.94% |
| Beta | 0.85 | 0.52 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs CAH in plain English
- TMO is the bigger company — about 4.9× the market cap of CAH.
- CAH is cheaper on earnings (P/E 30.5 vs 36.4).
- TMO is growing revenue faster (10% vs 6%).
- CAH has the higher dividend yield (0.94% vs 0.28%).
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
CAH return calculator
See what $1,000 in Cardinal Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.